Conference Call with Max Healthcare Institute Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Facilities company Max Healthcare Institute announced Q2FY25 results Gross Revenue stood at Rs 2,228 crore for Q2FY25, growth of +22% YoY & +10% QoQ. Network Operating EBITDA was Rs 591 crore excluding Rs 18 crore loss at MSSH Dwarka and Jaypee Hospital one-time transaction expenses of Rs 7 crore, a growth of +19% YoY. Operating Margin excluding loss at MSSH Dwarka and Jaypee Hospital one-time transaction expenses stood at 28.2% compared to 28.7% in Q2FY24 and 25.8% in Q1FY25. PAT stood at Rs 349 crore in Q2FY25 Vs Rs 338 crore in Q2FY24 and Rs 295 crore in Q1FY25. PAT excluding net loss of Rs 26 crore from MSSH Dwarka was Rs 375 crore. Free Cash from Operations was Rs 464 crore in Q2FY25. Of this, Rs 217 crore was deployed for the ongoing expansion plans and upgradation of facilities at New Units. Net Cash as on Sep 30, 2024 was Rs 313 crore. EBITDA per bed,* was Rs 74.5 lakh compared to Rs 75.0 lakh in Q2FY24 and Rs 70.9 lakh in Q1FY25 Abhay Soi, Chairman and Managing Director, Max Healthcare Institute, said: “With the successful launch of MSSH Dwarka and acquisition of Jaypee Hospital, Noida, we have significantly augmented our capacity and capabilities to deliver high quality patient centric care in NCR. We are encouraged by the enthusiastic response and strong community support to our healthcare offeringsin the new geographies, leading to exceptional performance at New Units. With the planned expansions coming on stream in FY26, we are set to further enhance our capabilities, widen our reach, and deepen our services to cater to the varied needs of our patients.” Result PDF